Influence of angiotensin-converting enzyme inhibitor enalaprilat on endothelial-derived substances in the critically ill

被引:40
作者
Boldt, J [1 ]
Papsdorf, M
Kumle, B
Piper, S
Hempelmann, G
机构
[1] Klinikum Stadt Ludwigshafen, Dept Anesthesiol & Intens Care Med, D-6700 Ludwigshafen, Germany
[2] Univ Giessen, Dept Anesthesiol & Intens Care Med, Giessen, Germany
关键词
angiotensin-converting enzyme; enalaprilat; endothelium; angiotensin; endothelin; critically ill; inflammation; adhesion molecules; thrombomodulin; sepsis;
D O I
10.1097/00003246-199810000-00018
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To assess the effects of the angiotensin-converting enzyme inhibitor enalaprilat on endothelial cells in septic patients. Design: Prospective, randomized, placebo-controlled, blinded study. Setting: Clinical investigation on a surgical intensive care unit of a university hospital. Patients: Forty surgical septic patients (noncardiac/nonneurosurgical patients). Interventions: After inclusion in the study and after baseline data were obtained, either 0.25 mg/hr (enalaprilat group, n = 20) or saline solution as placebo (control group, n = 20) was continuously given and continued throughout the following 5 days. Measurements and Main Results: Extensive hemodynamic monitoring was carried out in all patients. Plasma concentrations of endothelin-1, angiotensin II, soluble thrombomodulin, and soluble adhesion molecules (endothelial leukocyte adhesion molecule-1, intercellular adhesion molecule-1, vascular cell adhesion molecule 1,and granule membrane protein-140) were measured from arterial blood samples. All measurements were carried out before the start of the infusion ("baseline" values) and daily during the following 5 days. All endothelial-derived substances (thrombomodulin, endothelin-1, and all soluble adhesion molecules) were similarly increased beyond normal in both group. Endothelin-1 increased only in the untreated control patients (from 6.9 +/- 0.7 to 14.3 +/- 1.4 mg/mL). Soluble thrombomodulin increased in the untreated control patients (from 58 +/- 9 to 79 +/- 14 ng/mL [p<.05]), but significantly decreased in the enalaprilat treated patients. Soluble adhesion molecules increased in the untreated control group (endothelial leukocyte adhesion molecule from 92 +/- 14 to 192 +/- 29 ng/mL; intercellular adhesion molecule-1 from 480 +/- 110 to 850 +/- 119 ng/mL) and returned almost to normal values in the enalaprilat patients. The survival rate did not differ significantly between the two groups. Control patients developed severe sepsis and septic shock more often than the enalaprilat-treated group. Conclusions: The complex pathogenesis of endothelial function abnormalities in sepsis may offer a large number of pharmaco logic interventions. Administration of the angiotensin converting enzyme inhibitor enalaprilat resulted in a reduced release of soluble endothelial derived substances into the circulating blood, which may indicate an improved endothelial function. The specific actions of enalaprilat on the endothelium have to be elucidated in further studies.
引用
收藏
页码:1663 / 1670
页数:8
相关论文
共 37 条
[1]   LEUKOCYTE-ENDOTHELIAL INTERACTIONS AND REGULATION OF LEUKOCYTE MIGRATION [J].
ADAMS, DH ;
SHAW, S .
LANCET, 1994, 343 (8901) :831-836
[2]  
ANGGARD EE, 1990, BLOOD VESSELS, V27, P269
[3]   PROTECTION OF THE SMALL-INTESTINE FROM NONOCCLUSIVE MESENTERIC ISCHEMIC-INJURY DUE TO CARDIOGENIC-SHOCK [J].
BAILEY, RW ;
BULKLEY, GB ;
HAMILTON, SR ;
MORRIS, JB ;
HAGLUND, UH .
AMERICAN JOURNAL OF SURGERY, 1987, 153 (01) :108-116
[4]  
BIEBUYCK JF, 1994, ANESTHESIOLOGY, V80, P892
[5]  
BOFFA MC, 1991, NOUV REV FR HEMATOL, V33, P529
[6]  
BOLDT J, 1994, CLIN INTENSIVE CARE, V5, P164
[7]   AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[8]   ENDOTHELIUM-DEPENDENT VASCULAR-RESPONSES - MEDIATORS AND MECHANISMS [J].
BRENNER, BM ;
TROY, JL ;
BALLERMANN, BJ .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (05) :1373-1378
[9]  
COLSON P, 1993, J CARDIOTHOR VASC AN, V6, P734
[10]   INCREASED CIRCULATING ADHESION MOLECULE CONCENTRATIONS IN PATIENTS WITH THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME - A PROSPECTIVE COHORT STUDY [J].
COWLEY, HC ;
HENEY, D ;
GEARING, AJH ;
HEMINGWAY, I ;
WEBSTER, NR .
CRITICAL CARE MEDICINE, 1994, 22 (04) :651-657